EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY-NC-ND 4.0

Utilizing both IgA tissue transglutaminase and IgG-deamidated gliadin peptide antibodies offers accurate celiac disease diagnosis without duodenal biopsy

Fabiana Zingone, Gary L Norman, Edgardo Smecuol, Daria Maniero, Antonio Carroccio, Federico Biagi, Juan P Stefanolo, Sonia Niveloni, Geoffrey Holmes, Vincenzo Villanacci, Antonella Santonicola, Julio C Bai und 1 weitere

Digestive and Liver Disease · 2025-02 · 57 (2) · 609-615

DOI: 10.1016/j.dld.2024.10.010 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Digestive and Liver Disease, 2025-02. Verfasst von Fabiana Zingone und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Oncology, Gastroenterology, University of Padua, Padua, Italy; Gastroenterology Unit, Azienda Ospedale Università di Padova, P…. Hauptthemen laut MEDLINE: Celiac Disease, Immunoglobulin A, Gliadin, Immunoglobulin G. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Gastroenterologists still raise concerns about adopting a non-biopsy strategy for diagnosing celiac disease (CeD) in adults. AIM: To assess the performance of the concurrent detection of two autoantibodies targeting two independent antigens, tissue transglutaminase (tTG) and deamidated gliadin peptides (DGP). METHODS: This prospective, multicenter, binational study collected consecutive patients with a high pre-test probability for CeD. Between 2018 and 2020, adults were enrolled at four Italian and one Argentinian center. Serology was also blindly analyzed by a central laboratory (Werfen, San Diego, USA) for tTG IgA and DGP IgG by Aptiva Particle-based multi-analyte technology (PMAT) assays. CeD diagnosis required histological confirmation of Marsh 3 damage. RESULTS: 181 adult patients with suspected CeD were enrolled (134 with histological diagnosis of CeD and 47 not histologically confirmed as CeD). Patients positive for both tTG IgA and DGP IgG (double positive) were predictive of CeD in 92.5 % of patients at >1x upper limit of normal (ULN). Double positivity for tTG IgA and DGP IgG, both at >10x ULN, had a 100 % positive predictive value for the presence of Marsh 3 histology. CONCLUSIONS: Incorporating DGP IgG alongside tTG IgA in a single-step approach can be considered a valid confirmatory strategy for definitive non-biopsy diagnosis of CeD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Celiac DiseaseImmunoglobulin AGliadinImmunoglobulin GAutoantibodiesTransglutaminasesGTP-Binding ProteinsHumansMaleFemaleProspective StudiesMiddle AgedAdultProtein Glutamine gamma Glutamyltransferase 2BiopsyAgedDuodenumItalySensitivity and SpecificityPredictive Value of Tests

Stichwörter der Autor:innen

Celiac diseaseNon-biopsy diagnosisSerologic diagnosis

Substanzen

Immunoglobulin AGliadinImmunoglobulin GAutoantibodiesTransglutaminasesProtein Glutamine gamma Glutamyltransferase 2GTP-Binding Proteins

Autor:innen und Institutionen

  • Department of Surgery, Oncology, Gastroenterology, University of Padua, Padua, Italy; Gastroenterology Unit, Azienda Ospedale Università di Padova, Padua, Italy.
  • Research and Development, Headquarters & Technology Center Autoimmunity, Werfen, San Diego, CA, USA.
  • Small Bowel Section, Dr. C. Bonorino Udaondo Gastroenterology Hospital, Buenos Aires, Argentina.
  • Department of Surgery, Oncology, Gastroenterology, University of Padua, Padua, Italy.
  • Unit of Internal Medicine, PROMISE Department, Villa Sofia Cervello United Hospitals - University of Palermo, Palermo, Italy.
  • Department of Internal Medicine and Therapeutics, University of Pavia, Pavia, Italy; Gastroenterology Unit of Pavia Institute, Istituti Clinici Scientifici Maugeri IRCCS, Pavia, Italy.

Zitieren

APA

Zingone, F., Norman, G. L., Smecuol, E., Maniero, D., Carroccio, A., Biagi, F., Stefanolo, J. P., Niveloni, S., Holmes, G., Villanacci, V., Santonicola, A., Bai, J. C., & Ciacci, C. (2025). Utilizing both IgA tissue transglutaminase and IgG-deamidated gliadin peptide antibodies offers accurate celiac disease diagnosis without duodenal biopsy. Digestive and Liver Disease, 57(2), 609-615. https://doi.org/10.1016/j.dld.2024.10.010

Vancouver

Zingone F, Norman GL, Smecuol E, Maniero D, Carroccio A, Biagi F, et al. Utilizing both IgA tissue transglutaminase and IgG-deamidated gliadin peptide antibodies offers accurate celiac disease diagnosis without duodenal biopsy. Digestive and Liver Disease. 2025;57(2):609-615. doi:10.1016/j.dld.2024.10.010

BibTeX
@article{Zingone2025,
  author = {Zingone, Fabiana and Norman, Gary L and Smecuol, Edgardo and Maniero, Daria and Carroccio, Antonio and Biagi, Federico and Stefanolo, Juan P and Niveloni, Sonia and Holmes, Geoffrey and Villanacci, Vincenzo and Santonicola, Antonella and Bai, Julio C and Ciacci, Carolina},
  title = {Utilizing both IgA tissue transglutaminase and IgG-deamidated gliadin peptide antibodies offers accurate celiac disease diagnosis without duodenal biopsy},
  journal = {Digestive and Liver Disease},
  year = {2025},
  volume = {57},
  number = {2},
  pages = {609--615},
  doi = {10.1016/j.dld.2024.10.010}
}
Kostenlos starten →